Loading institutional data...
Loading institutional data...
Strong institutional accumulation: ownership increased +4.97% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $13.36 today, the market must believe free cash flow compounds 19.9%/yr for a decade (off $3M normalized FCF).
The market's 19.9% is more optimistic than its 8-yr track record.
2-stage DCF · 0.01B shares · net debt -$5M
mean 157.1% · volatility σ 369% · implied rate exceeded in 3/4 yrs
Central path = implied 19.9%/yr growth; shaded band = ±1σ (369%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.6M 100.0% | $64.9M 100.0% | $72.2M 100.0% | $72.2M 100.0% | $57.4M 100.0% | $43.0M 100.0% | $55.3M 100.0% | $50.2M 100.0% | $23.0M 100.0% | $30.2M 100.0% |
| Cost of Revenue | $53.9M 66.8% | $46.0M 70.9% | $52.6M 72.9% | $52.6M 72.9% | $39.7M 69.1% | $31.5M 73.1% | $39.7M 71.7% | $33.1M 65.9% | $16.0M 69.6% | $21.8M 72.0% |
| Cost of Products | — | — | — | — | — | — | — | — | $22.2M 96.8% | $21.8M 72.0% |
| Gross Profit | $26.7M 33.2% | $18.9M 29.1% | $19.5M 27.1% | $19.5M 27.1% | $17.8M 30.9% | $11.6M 26.9% | $15.6M 28.3% | $17.1M 34.1% | $7.0M 30.4% | $8.5M 28.0% |
| Research & Development | $3.0M 3.7% | $2.8M 4.3% | $3.2M 4.4% | $3.2M 4.4% | $1.5M 2.6% | $2.0M 4.6% | $1.5M 2.7% | $1.5M 2.9% | $824K 3.6% | $747K 2.5% |
| Selling, General & Admin | $22.0M 27.3% | $18.9M 29.2% | $20.2M 28.0% | $20.2M 28.0% | $11.9M 20.7% | $10.0M 23.2% | $9.7M 17.6% | $8.2M 16.3% | $6.0M 25.9% | $9.6M 31.6% |
| Total Operating Expenses | $25.0M 31.0% | $21.7M 33.4% | $23.3M 32.3% | $23.3M 32.3% | $13.4M 23.3% | $12.0M 27.8% | $11.2M 20.2% | $9.7M 19.2% | $6.8M 29.5% | $13.2M 43.5% |
| Operating Income | $1.8M 2.2% | -$2.8M -4.4% | -$3.8M -5.3% | -$3.8M -5.3% | $4.4M 7.7% | -$403K -0.9% | $4.5M 8.1% | $7.4M 14.8% | $203K 0.9% | -$4.7M -15.5% |
| Other Income (Expense), net | -$972K -1.2% | -$980K -1.5% | -$453K -0.6% | -$453K -0.6% | $2.8M 4.9% | -$45K -0.1% | $98K 0.2% | $47K 0.1% | $29K 0.1% | $5K 0.0% |
| Pretax Income | $813K 1.0% | -$3.8M -5.9% | -$4.3M -5.9% | -$4.3M -5.9% | $7.2M 12.6% | -$448K -1.0% | $4.6M 8.2% | $7.5M 14.9% | $232K 1.0% | -$4.7M -15.5% |
| Income Tax Expense | $738K 0.9% | $2.8M 4.3% | -$1.2M -1.6% | -$1.2M -1.6% | $1.0M 1.8% | -$367K -0.9% | $1.0M 1.9% | $1.5M 2.9% | $62K 0.3% | -$652K -2.2% |
| Net Income | $75K 0.1% | -$6.6M -10.2% | -$3.1M -4.3% | -$3.1M -4.3% | $6.2M 10.8% | -$81K -0.2% | $3.5M 6.4% | $5.8M 11.6% | $382K 1.7% | -$4.1M -13.5% |
| Per Share | ||||||||||
| EPS (Basic) | $0.01 | $-0.63 | $-0.30 | $-0.30 | $0.62 | $-0.01 | $0.38 | $0.64 | $0.04 | $-0.47 |
| EPS (Diluted) | $0.01 | $-0.63 | $-0.30 | $-0.30 | $0.61 | $-0.01 | $0.36 | $0.61 | $0.04 | $-0.47 |
| Weighted Avg Shares (Basic) | 10.6M | 10.5M | 10.3M | 10.3M | 10.0M | 9.7M | 9.4M | 9.1M | 8.8M | 8.8M |
| Weighted Avg Shares (Diluted) | 10.8M | 10.5M | 10.3M | 10.3M | 10.2M | 9.7M | 9.9M | 9.6M | 8.9M | 8.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
7/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-08-05
No material risks flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 65.9 | 71.7 | 73.1 | 69.1 | 72.9 | 72.9 | 70.9 | 66.8 |
| Gross Profit | 34.1 | 28.3 | 26.9 | 30.9 | 27.1 | 27.1 | 29.1 | 33.2 |
| R&D | 2.9 | 2.7 | 4.6 | 2.6 | 4.4 | 4.4 | 4.3 | 3.7 |
| SG&A | 16.3 | 17.6 | 23.2 | 20.7 | 28.0 | 28.0 | 29.2 | 27.3 |
| Operating Income | 14.8 | 8.1 | -0.9 | 7.7 | -5.3 | -5.3 | -4.4 | 2.2 |
| Income Tax | 2.9 | 1.9 | -0.9 | 1.8 | -1.6 | -1.6 | 4.3 | 0.9 |
| Net Income | 11.6 | 6.4 | -0.2 | 10.8 | -4.3 | -4.3 | -10.2 | 0.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on RFIL: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 633 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $33.13T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $405.3B | 46.3× | 32.2× | 6.0× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $399.8B | 46.8× | — | 8.7× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $298.4B | 44.8× | 21.3× | 3.4× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| ABBNY | $187.8B | 50.7× | 33.5× | 5.8× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $175.3B | 24.7× | 16.7× | 7.2× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $173.5B | 42.8× | — | 6.3× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| DE | $165.5B | 33.1× | — | 3.6× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| HON | $157.6B | 33.7× | 18.9× | 4.2× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| HTHIF | $153.6B | 0.7× | — | 0.0× | 3.9% | 25.2% | 2.6% | 16.6% | 7.4% | — | 2 |
| LMT | $132.3B | 26.9× | 17.0× | 1.8× | 5.6% | 10.2% | 6.7% | 74.6% | 18.4% | 2.4× | 2,807 |
| PH | $127.9B | 36.8× | 28.7× | 6.4× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| HWM | $117.0B | 78.5× | 51.2× | 14.2× | 11.1% | — | 18.3% | 28.2% | 18.4% | 1.2× | 1,399 |
| ADP | $109.5B | 27.1× | — | 5.3× | 7.1% | 46.0% | 19.8% | 65.9% | 40.1% | — | 2,179 |
| TT | $107.8B | 37.3× | 26.5× | 5.1× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $106.3B | 81.5× | 50.3× | 10.4× | 27.7% | 36.3% | 13.0% | 33.8% | 19.5% | 1.4× | 1,748 |
| GD | $103.9B | 24.9× | 18.1× | 2.0× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| PWR | $102.2B | 100.4× | 50.3× | 3.6× | 20.3% | 15.0% | 3.7% | 11.7% | 11.7% | 0.0× | 1,659 |
| JCI | $100.1B | 30.6× | — | 4.2× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| MMM | $96.6B | 30.4× | 18.4× | 3.9× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| CSX | $95.1B | 33.2× | 15.3× | 6.8× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| EMR | $91.4B | 40.2× | — | 5.1× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| UPS | $91.4B | 16.4× | 10.1× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| WM | $90.4B | 33.5× | 12.7× | 3.6× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| CMI | $89.7B | 31.7× | 16.9× | 2.7× | -1.3% | 25.3% | 8.8% | 23.9% | 23.9% | — | 1,877 |
| RFIL | $143M | 1336.0× | 32.5× | 1.8× | 24.3% | 33.2% | 0.1% | 0.2% | 0.2% | — | 64 |
Peers = companies sharing RFIL's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.